The efficacy of a 'master switch gene' HIF-1alpha in a porcine model of chronic myocardial ischaemia.
about
Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alphaHypoxia-based strategies for angiogenic induction: the dawn of a new era for ischemia therapy and tissue regenerationHypoxia-inducible factors and the response to hypoxic stressVEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trialPeptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis.The Role of Capillaries in the Lesser Ailments of Old Age and in Alzheimer's Disease and Vascular Dementia: The Potential of Pro-Therapeutic Angiogenesis.The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure.Cardiovascular gene therapy: current status and therapeutic potential.Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease.Noninvasive imaging of hypoxia-inducible factor-1α gene therapy for myocardial ischemiaGene therapy to treat cardiovascular disease.Cardiac gene therapy in large animals: bridge from bench to bedside.Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors.Elevated cell invasion is induced by hypoxia in a human pituitary adenoma cell line.Gene delivery nanoparticles to modulate angiogenesis.Evaluation of the porcine ameroid constrictor model of myocardial ischemia for therapeutic angiogenesis studies.Myocardial Expression of Macrophage Migration Inhibitory Factor in Patients with Heart Failure.
P2860
Q24308024-7AEFBEE3-4E8B-43BA-96AB-C5BA26A8849AQ24613344-C439CC90-51F0-40B2-A101-F1A1FE8D0436Q24629323-65E0E60F-AB23-4707-8FF6-D7719D11F22DQ33713721-7C9A868B-3477-4C50-AF50-7BE6D23AEBF5Q34479397-F1C14768-BD9C-4219-B674-0E4D2AAB149EQ34533560-89F2C7DA-EE48-472D-8A4B-B52F5AB284F1Q35065245-4A6615D2-469E-47A1-8F5D-671E3303E6C6Q35995220-A70E870A-980F-4861-9B9D-9ADAA2000D33Q36809751-7E2876F9-439D-4EF4-9DE5-22FACEF5DFDFQ37233533-FEFE6CB0-24DC-40AF-B148-95BECEE893ABQ37310450-7A976D73-9A19-4D5D-9EB6-873FC06E23ACQ37981008-5ECE01CA-0CAD-4F23-8143-FE2BA050795BQ38081027-5FE683AE-28B2-457F-92BA-EE80118FDA2AQ38306134-A0F15507-A335-4765-A651-3B7F24250D80Q39027588-E9C52FD1-2DE7-462F-BF9B-588C3BB31202Q45861500-181774FD-557C-479C-B0C7-CBD5FD29B9A5Q47108429-8337CC57-A5D4-4081-B8E4-B49E7FA9AC6B
P2860
The efficacy of a 'master switch gene' HIF-1alpha in a porcine model of chronic myocardial ischaemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The efficacy of a 'master swit ...... chronic myocardial ischaemia.
@en
The efficacy of a 'master swit ...... chronic myocardial ischaemia.
@nl
type
label
The efficacy of a 'master swit ...... chronic myocardial ischaemia.
@en
The efficacy of a 'master swit ...... chronic myocardial ischaemia.
@nl
prefLabel
The efficacy of a 'master swit ...... chronic myocardial ischaemia.
@en
The efficacy of a 'master swit ...... chronic myocardial ischaemia.
@nl
P2093
P2860
P356
P1476
The efficacy of a 'master swit ...... chronic myocardial ischaemia.
@en
P2093
Amanda Heinl-Green
Duncan M Geddes
Eric W F W Alton
Felix M Munkonge
Karen Vincent
Oliver Frass
Peter W Radke
P2860
P304
P356
10.1093/EURHEARTJ/EHI223
P577
2005-04-08T00:00:00Z